N-Oxide Lidocaine-d
Cat. No.：YN350306
| 产品名称: | N-Oxide Lidocaine-d |
| CAS No.: | 6108-05-0 |
| Chemical Name: | 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide Hydrochloride Monohydrate; Basicaina Monohydrate; Batixim Monohydrate; Dynexan Monohydrate; Heweneural Monohydrate; Licain Monohydrate; |
| Synonyms: | Lignocaine hydrochloride hydrate |
| 分子量: | 288.81 |
| 分子式: | C14H25ClN2O2 |
| SMILES: | O.Cl.CCN(CC(NC1C(C)=CC=CC=1C)=O)CC |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Lidocaine (Lignocaine) hydrochloride hydrate 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride hydrate 通过调节 miR-145 表达和进一步抑制MEK/ERK和NF-κB信号通路来减少胃癌细胞的生长，迁移和侵袭。Lidocaine hydrochloride hydrate 是一种酰胺衍生物，可用于研究室性心律失常。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Duce, R., et al.: J. Pharmacol. Exp. Ther., 179, 580 (1971), Kronberg, G.H., et al.: J. Med. Chem., 16, 739 (1973), Groningsson, K., et al.: Anal. Profiles Drug Subs., 14, 207 (1985), Davies, P.S., et al.: Drugs, 64, 937 (2004),
